VINAY KAMAT: Open Payments
NPI 1760522916 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$39,924 in 45 payments from 10 companies in 2025. Trend: 2023 $34,232 · 2024 $15,163 · 2025 $39,924
Speaker / faculty: $36,055Travel & lodging: $2,777Food & beverage: $1,092
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 33 | $39,642 |
| ABBVIE INC. | 4 | $77 |
| GENZYME CORPORATION | 1 | $74 |
| Azurity Pharmaceuticals, Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| HEARTFLOW, INC. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: Wegovy, KEVZARA, UBRELVY, VRAYLAR, ELIQUIS, FFRct, SHINGRIX, JARDIANCE.
Industry payments across MO — which companies pay providers there.
